Tech Company Financing Transactions
Owlstone Medical Funding Round
Ventura Capital, Aviva Ventures and Bill & Melinda Gates Foundation invested in a $27 million Series E funding round for Owlstone Medical. The round closed on 1/15/2025.
Transaction Overview
Company Name
Announced On
1/15/2025
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series E
Investors
Proceeds Purpose
The company intends to use the funds to support the ongoing development of its proprietary Breath Biopsy® platform and the development and commercialization of novel diagnostic tests and point of care devices.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
183 Cambridge Science Park Milton Road
Cambridge, CB4 0GJ
UK
Cambridge, CB4 0GJ
UK
Phone
Website
Email Address
Not Recorded
Overview
Owlstone Medical is developing a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease. Our mission is to save 100,000 lives and $1.5B in healthcare costs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Billy Boyle
Chief Financial Officer
Pam Lauder
VP - Bus. Development
Elizabeth Crone
VP - General Counsel
Veronika Koenig-Roach
VP - Product Management
Martin Nash
Browse more venture capital transactions:
Prev: 1/15/2025: Opteam venture capital transaction
Next: 1/15/2025: Brickken venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs